Rodrigues Murilo Wendeborn, Bastos Thais, Gonçalves Annelise Nicotti, Cardillo José Augusto, Messias André, de Souza Eduardo Cunha, Jorge Rodrigo
Division of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Department of Ophthalmology, CRESEP Institution, Araraquara, Brazil.
Int J Retina Vitreous. 2023 Sep 1;9(1):53. doi: 10.1186/s40942-023-00483-8.
First described by Gaucher and associates in 2008, dome-shaped macula (DSM) is an anterior convex protrusion of the macula visible on OCT (optical coherence tomography). Visual impairment in DSM results mainly from sub-foveal serous retinal detachment (SRD). Herein, this original study from retrospective data analysis evaluate the anatomical and functional effects of Pascal short-pulse (SP) laser plus endpoint management (EpM) subthreshold diffuse laser (SDL) in patients with SRD due to DSM.
This retrospective study included seven consecutive patients (eight eyes) with SRD secondary to dome-shaped macula who underwent a comprehensive ophthalmological evaluation including logMAR BCVA, slit-lamp biomicroscopy, indirect ophthalmoscopy, and spectral-domain optical coherence tomography (SD-OCT) (Spectralis; Heidelberg Engineering, Germany) before combined Pascal SP laser plus EpM-SDL with 1 to 6 month intervals, postoperatively, with a mean ± standard error (SE) follow-up time of 12.92 ± 1.34 months.
Eight eyes from seven patients were analyzed in this study. At baseline, mean BCVA (LogMAR) ± standard error (SE) and mean CST (central subfield thickness)(µm) ± SE were 0.6125 ± 0.14 and 412.50 ± 24.65, respectively. After a mean follow-up time of 12.92 ± 1.34 months, mean CST (µm) ± SE and BCVA (LogMAR) ± SE were 294.75 ± 19.68 (p = 0.0078) and 0.4537 ± 0.12 (p = 0.0313), respectively. A statistically significant reduction in mean CST and an improvement in mean BCVA were noted after SRD resolution with laser therapy application. The mean serous retinal detachment resolution time (months) ± SE was 3.75 ± 1.08. No adverse events were registered, including enlargement of atrophic alterations and choroidal neovascularization.
The novel combined laser modality with Pascal SP laser plus EpM-SDL treatment may induce subretinal fluid regression and BCVA improvement 1 year after treatment in DSM patients with SRD.
2008年由高雪及其同事首次描述,穹窿状黄斑(DSM)是一种在光学相干断层扫描(OCT)上可见的黄斑前凸性隆起。DSM导致的视力损害主要源于黄斑下浆液性视网膜脱离(SRD)。在此,这项基于回顾性数据分析的原创性研究评估了帕斯卡短脉冲(SP)激光联合终点管理(EpM)阈下弥漫性激光(SDL)对因DSM导致SRD患者的解剖学和功能影响。
这项回顾性研究纳入了7例连续的因穹窿状黄斑继发SRD的患者(8只眼),这些患者在接受帕斯卡SP激光联合EpM-SDL治疗前、术后间隔1至6个月进行了包括logMAR最佳矫正视力(BCVA)、裂隙灯生物显微镜检查、间接检眼镜检查和光谱域光学相干断层扫描(SD-OCT)(Spectralis;德国海德堡工程公司)在内的全面眼科评估,平均随访时间为12.92±1.34个月。
本研究分析了7例患者的8只眼。基线时,平均BCVA(LogMAR)±标准误差(SE)和平均中心子野厚度(CST)(μm)±SE分别为0.6125±0.14和412.50±24.65。平均随访12.92±1.34个月后,平均CST(μm)±SE和BCVA(LogMAR)±SE分别为294.75±19.68(p = 0.0078)和0.4537±(p = 0.0313)。激光治疗使SRD消退后,平均CST有统计学意义的降低,平均BCVA有所改善。浆液性视网膜脱离的平均消退时间(月)±SE为3.75±1.08。未记录到不良事件,包括萎缩性改变扩大和脉络膜新生血管形成。
帕斯卡SP激光联合EpM-SDL治疗的新型联合激光模式可能会使DSM合并SRD患者在治疗1年后出现视网膜下液消退和BCVA改善。